1. HOME
2. Research Insight
3. IQVIA Holdings, Inc. (US) and Medable Inc. (US) are Leading Players in the Electronic Clinical Outcome Assessment (eCOA) Solution Market

The Electronic Clinical Outcome Assessment (eCOA) Solutions market is projected to reach USD  4.1 billion by 2029 from USD 1.9 billion in 2024, at a CAGR 16.3% from 2024  to 2029. Electronic Clinical Outcome Assessment (eCOA) Solutions refers to the use of electronic platforms or devices such as smartphones, tablets, or computers to collect patient-reported data on their health outcomes, symptoms, quality of life, or treatment responses in clinical trials or healthcare settings. The growth of this market is driven by a rise in demand for cost-effective data collection solutions, and increase in demand for effective monitoring of clinical data. However, scarcity of skilled personnel to operate the electronic clinical outcome assessment solutions inhibits the market growth.

The electronic clinical outcome assessment (eCOA) solutions market is consolidated and is dominated by key players. The major players operating in this market IQVIA (US), Medidata (US), ICON Plc (Ireland), Signant Health (US), Clario (US), Oracle Corporation (US), Medable Inc. (US), Merative (US), Parexel International (MA) Corporation (US), Climedo Health GmbH (Germany), Healthentia (Belgium), Veeva Systems (US), assisTek (US), Curebase Inc. (US), Castor (US), EvidentIQ Group GmbH (Germany), YPrime, LLC (US), Clinical Ink (US), Clinion (US), Kayentis (France), TransPerfect (US), ObvioHealth USA, Inc. (US), WCG Clinical (Germany), ClinCapture (US), and Cloudbyz (US).

To know about the assumptions considered for the study download the pdf brochure

IQVIA HOLDINGS INC, (US)

IQVIA is the leading player in the eCOA solutions market. The company's leading position in the market can be attributed to various factors, such as its robust technology and service capabilities, good client relationships, diversified service offerings, and its ability to enhance the penetration of its offerings through significant R&D expenditure and product innovation. IQVIA focuses on product launches and agreements & partnerships to sustain its market position. The company has a wide geographical presence in over 100 countries across North America, Europe, Asia, Latin America, and Africa. The company has the largest and most comprehensive collection of healthcare data across the globe, including over 1.2 billion comprehensive prescription and promotional datasets, patient records, electronic medical records, genomic datasets, and datasets from social media.

Medidata (US)

Medidata is one of the leading providers of cloud-based solutions for clinical trials. The company offers a comprehensive suite of eCOA solutions designed to streamline data collection and improve patient engagement in clinical research. As part of its business overview, Medidata emphasizes its commitment to revolutionizing the way clinical trials are conducted by harnessing the power of technology to enhance efficiency, accuracy, and patient-centricity. The company's strong position in the market is due to its research capabilities and innovative product portfolio. In fiscal year 2022, the company’s research & development expenses increased by 15.5% from USD 949 million in 2021 to USD 1,087 million in 2022, representing 19.2% of its net sales. Medidata has offices and facilities across North America, Europe, Asia Pacific, and Latin America. These offices serve as hubs for sales, customer support, research & development, and other business functions, allowing Medidata to effectively serve customers and partners across different regions.

Related Reports:

Electronic Clinical Outcome Assessment (eCOA) Solution Market by Modality (Wearable, Mobile, BYOD), Type (PRO, CLINRO, OBSRO, PERFO), Application ((Clinical trial (Onco, Rare, Mental Health)), RWE, Registery), End User - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]